ATYR Pharma
ATYR----
ATYR Pharma (ATYR)
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
ATYR Pharma Analyst Rating
View MoreForecast & Rating
Jul 16, 2026Price forecast
$2.86503.66%
Forecast & RatingBuy
9analysts
- Strong buy22.22%
- Buy22.22%
- Hold55.56%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 1 day ago, 04:13 AM
From Labor Markets to the AI Fringe: A Cross-Section of the 2026 Economy
- PUBT · Jul 15 at 07:02 AM
aTyr Pharma submits FDA protocol for planned Phase 3 efzofitimod sarcoidosis study
- Unusual Whales · Jul 15 at 07:02 AM
aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026
- Quartr · Jun 25 at 03:55 PM
ATYR: Efzofitimod advances toward approval with a new phase III trial targeting restrictive sarcoidosis
- nasdaq · May 29 at 08:35 AM
Pre-Market Movers: REPL, BMGL, SPRC Chart The Course
- benzinga_article · May 28 at 04:05 PM
12 Health Care Stocks Moving In Thursday's After-Market Session
